ArticleWiener klinische Wochenschrift2024

Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.

Leila Ronceray et al.PubMed ↗Publisher ↗

No numbers read from the abstract.